Brentuximab
Product Specifications
CAS Number
2088770-90-3
Target
ADC Antibody, TNF
Related Pathways
Antibody-drug Conjugate/ADC Related, Apoptosis
Purity
0.992
Bioactivity
Brentuximab, a chimeric antibody targeting CD30, is a naked antibody to Brentuximab vedotin. It possesses antitumor activity and may be used to study relapsed or refractory Hodgkin's lymphoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3750104 1.0 µg DNA
S1pr5 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details 
22805062 1.0 µg DNA
GTF2IRD2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details MBS6010676-01 0.2 mL
NPTN, NT (NPTN, SDFR1, SDR1, Neuroplastin, Stromal cell-derived receptor 1)
Sign In for Pricing
View Details